Figure 3.
Overall survival (OS) of DEB-TACE treatment. Mean OS of all patients was 384 days [95% confidence interval (CI): 375–393 days], and estimated 6-month OS was 94.6% ± 1.4%.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.